Both of these companies recently got their first approvals and received lucrative rare pediatric disease Priority Review Vouchers. I think both have potential as long-term investments.
good work! Love it! Just one remark from my side: Mirum needs to pay milestones plus considerable royalties to shire. Albo does not have to pay this
good work! Love it! Just one remark from my side: Mirum needs to pay milestones plus considerable royalties to shire. Albo does not have to pay this